Understand the source comparison
Comparison to other compound safety profiles
Putting ACE-031 side effects in context helps researchers assess relative risk. Compared to anabolic steroids, the side effect profile is fundamentally different. Steroids produce androgenic effects (acne, hair loss, virilization), hepatotoxicity, cardiovascul
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Putting ACE-031 side effects in context helps researchers assess relative risk. Compared to anabolic steroids, the side effect profile is fundamentally different. Steroids produce androgenic effects (acne, hair loss, virilization), hepatotoxicity, cardiovascular strain, and hormonal suppression. ACE-031 side effects were vascular in nature and mechanistically distinct.
- Compared to SARMs, which produce their own range of liver and hormonal concerns, ACE-031 represents a completely different risk category. The vascular effects seen with ACE-031 are unique to the ActRIIB pathway and do not occur with other muscle-building approaches.
- Compared to growth hormone secretagogues like ipamorelin or CJC-1295, ACE-031 carries higher vascular risk but potentially greater muscle-building efficacy. The risk-benefit calculation differs substantially between these compound classes.